Beta Glucan 500 and Biological Age and Immune Age

OvationLab

Status and phase: Not yet enrolling; Phase 2

Conditions: Aging

Treatments: Dietary Supplement: Beta Glucan

Study type: Interventional

Funder types: NETWORK

Identifiers

NCT07104929

BWH-002

Details and patient eligibility

About

The primary purpose of this study is to evaluate the effects of BWH Labs - Beta Glucan 500 on biomarkers of biological and immune age among healthy adults.

A single-arm, open-label prospective study will be conducted evaluating the impact of 12 weeks of supplementation with two capsules daily of Beta Glucan 500 on a variety of validated markers of biological and immune age on the comprehensive TruAge panel (TruDiagnostics, Lexington, KY).

Enrollment: 60 estimated patients

Sex: All

Ages: 40+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Adult females or males age ≥ 40 years
2. Ability to read and speak English
3. Previous completion of a TruDiagnostic TruAge test within the past three months to enable comparison of previous biomarkers to the same biomarkers after intervention
4. DunedinPACE estimate of aging >0.9

Exclusion criteria

1. Current diagnosis and treatment for an autoimmune condition
2. Current use of beta-glucan or mushroom dietary supplement
3. Known allergies to beta glucan, yeast, or mushrooms
4. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
5. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol
6. Participants unable to provide consent

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

Beta Glucan

Experimental group

Treatment:

Dietary Supplement: Beta Glucan